After the company's recent fall from grace, Amicus (NASDAQ: FOLD ) shares are showing new life, up double digits in late-day trading. Today's pop follows a press release announcing solid phase 2 results for one of Amicus' pipeline drugs. On the other side of the coin, today's biggest loser was a company called Accuray (NASDAQ: ARAY ) , a medical devices stock down some 20% today after pre-announcing quarterly results last night after the market closed.
What's inside Supernova?
If you're an investor looking for big long-term winners, Motley Fool co-founder David Gardner's picks have frequently trounced the market. How? Because he's always on the lookout for revolutionary stocks and recommends them before Wall Street catches on to their disruptive potential. If you're interested in how David discovers his winners, click here to get instant access to a personal tour behind David's Supernova service.